Inventor
HEDTJÄRN MAJ
DK15 patents
⚠️ This page may combine multiple inventors who share the name “HEDTJÄRN MAJ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE INNOVATION CT COPENHAGEN AS
10 patentsUS9879265B2Jan 30, 2018
Oligonucleotide conjugates
ROCHE INNOVATION CT COPENHAGEN AS17 citations92
US10494633B2Dec 3, 2019
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS8 citations91
US10739332B2Aug 11, 2020
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS6 citations82
US10718753B2Jul 21, 2020
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS5 citations82
US10443058B2Oct 15, 2019
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS1 citations71
US10385342B2Aug 20, 2019
Methods of treatment using antisense oligomers and conjugates targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS1 citations71
US10370668B2Aug 6, 2019
Manufacture of antisense oligomers and conjugates targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS1 citations71
US12421516B2Sep 23, 2025
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS0 citations61
US11739332B2Aug 29, 2023
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS0 citations61
US11091764B2Aug 17, 2021
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS0 citations61
HOFFMANN LA ROCHE
4 patentsUS11852627B2Dec 26, 2023
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE3 citations82
US11320421B2May 3, 2022
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE3 citations82
US12259380B2Mar 25, 2025
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE2 citations73
US12566172B2Mar 3, 2026
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE0 citations61